Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT00651261 · UNKNOWN
Trial details
- NCT number
- NCT00651261
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2016-07-01
- Enrollment
- 717
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.